Cornercap Investment Counsel’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-23,683
| Closed | -$494K | – | 220 |
|
|
2024
Q4 | $494K | Buy |
+23,683
| New | +$494K | 0.16% | 218 |
|
|
2024
Q2 | – | Sell |
-12,216
| Closed | -$195K | – | 615 |
|
|
2024
Q1 | $195K | Sell |
12,216
-1,171
| -9% | -$18.7K | 0.03% | 569 |
|
|
2023
Q4 | $225K | Sell |
13,387
-73,786
| -85% | -$1.24M | 0.04% | 517 |
|
|
2023
Q3 | $1.02M | Buy |
87,173
+30,938
| +55% | +$362K | 0.19% | 169 |
|
|
2023
Q2 | $756K | Hold |
56,235
| – | – | 0.13% | 330 |
|
|
2023
Q1 | $932K | Sell |
56,235
-17,183
| -23% | -$285K | 0.16% | 261 |
|
|
2022
Q4 | $1.37M | Sell |
73,418
-9,517
| -11% | -$177K | 0.24% | 108 |
|
|
2022
Q3 | $1.06M | Sell |
82,935
-67,124
| -45% | -$861K | 0.2% | 146 |
|
|
2022
Q2 | $1.05M | Buy |
150,059
+2,643
| +2% | +$18.5K | 0.18% | 184 |
|
|
2022
Q1 | $1.22M | Sell |
147,416
-10,786
| -7% | -$89.4K | 0.14% | 198 |
|
|
2021
Q4 | $1.07M | Sell |
158,202
-57,942
| -27% | -$392K | 0.15% | 265 |
|
|
2021
Q3 | $1.15M | Buy |
+216,144
| New | +$1.15M | 0.13% | 262 |
|